Drugs and other chemicals are usually metabolized in the liver in the drugmetabolizing enzyme system. The metabolites sometimes bind with cellular macromolecules and injure the cell directly or serve as new antigens to create immunologic injury in a delayed fashion. The immediate or toxic injury is dose-dependent, predictable and zonal in the liver lobule, usually in the central region. Carbon tetrachloride intoxication and acetaminophen overdose are examples of injury resulting from microsomal metabolism. Other iqiuries related to microsomal metabolism are those produced by vinyl chloride in polymerization plant workers and by methotrexate in psoriatics or leukemic children. Most adverse drug reactions affecting the liver and producing jaundice are unpredictable, delayed in onset, and only hypothetically related to microsomal metabolism in some instances. The two main types are cholestasis and viral-hepatitis-like. The former may be in a pure form, in which case it may be partly dose-dependent, or in a form mixed with hepatitis. Many drugs produce cholestasis in a small percentage of persons, and because the reaction is benign, albeit prolonged at times, such drugs continue to be used. The viral-hepatitis-like reaction involves few drugs and affects few persons, but can be fatal. The recognition that chronic hepatitis can be caused by drugs such as oxyphenisatin, a-methyldopa, and isoniazid has added a new dimension to the clinical problem of adverse drug reactions, which may extend to widely used and commonly available agents like aspirin.
Many chemicals including ingested drugs are cleared from the portal blood largely during the first passage through the liver. Drugs are either activated or inactivated by the liver, more often the latter [33] . Therefore, the dose must be such that a sufficient amount of an initially active drug can get past the liver or be released by it to have an effect on a target organ. Care is necessary in administration of drugs with regard to dosage, frequency of ad-ministration, relation to meals, other drugs, and the status of the liver. In the hepatocyte, metabolism of most drugs occurs in an enzyme complex called the microsomal biotransformation or xenobiotic system [4, 221. The main component of this system is a heme containing cytochrome monooxygenase, an enzyme that splits molecular oxygen, adding one oxygen atom to the substance beingmetabolized, and using the other to form water with hydrogen from the substrate. This process of simultaneous oxidation and reduction gives rise to the term 'mixed-function oxidase' for the heme enzyme.
Biotransformation
The biotransformation system is localized on the membranes of the hepittocellular endoplasmic reticulum [19] . There are two forms of this organelle. The rough form consists of a membrane-delimited channel lined by ribosomes where proteins like albumin, transferrin or fibrinogen and others are synthesized for export from the cell. From the ends of the rough profiles, vesicles and tubules of smooth endoplasmic reticulum bud off, and most drug metabolism occurs on or in these tubules. A few drugs like isoniazid or digitalis are acetylated in the soluble part of the cell [33] ; however, theze drugs, too, may be metabolized by microsomes in preparation for acetylation [7, 8] . Sulfation also occurs, but in the cytosol or soluble fraction with the help of adenosine triphosphatase [8] . The term microsome was devised before the era of molecular biology when organs were analyzed by homogenization and centrifugation. The particulate fraction sedimented by centrifugation at 100 000 g for several hours was called microsomal and later was found by electron microscopy to be largely endoplasmic reticulum. The membrane of the endoplasmic reticulum is a phospholipid bilayer interspersed with proteins, some of which extend all the way through the m e w brane and some of which are only on one side or the other. Cholesterol molecules dissolved in the fatty acid part of the phospholipid are distributed through the membrane, giving it rigidity. The fatty acids of the phospholipids are polyunsaturated. To keep the double bonds from being autooxidized in a chain reaction, scavengers are needed that will pick up free radica?s capable of inducing autooxidation. Such scavenging is one function of vitamin E. The most important enzyme protein of the membrane in terms of life support is glucose-6-phosphatase. It releases glucose to be delivered to the blood stream. In the absence of this enzyme, as in the hepatectomized animal, death from hypoglycemia occurs in an hour or two. Few changes in glucose metabolism are noted if cell injury occurs, because glucose-6-phosphatase in the membrane remains functioning until the cell is nearly dead. Therefore, hypoglycemia in liver injury is uncommon. However, the membrane has several other less critical but vital functions, including biotransformation or the metabolic alteration of biologically active substances that are more vulnerable to injury.
The macromolecular assembly containing the microsomal biotransformation system has natural substrates like steroid hormones or cholesterol and other endogenous substances that have to be prepared either for excretion or reutilization [4] . Substrates are bound to the heme containing cytochrome, either to the iron of the heme (iron ligand), or to the lipid of the liproprotein part of the cytochrome (lipid-binding site) [22] . For instance, aminopyrine or ethylmorphine is bound to the lipid-binding site whereas aniline is bound to the iron ligand, and the enzymes that act on these substrates are called aminopyrine or ethylmorphine demethylase and aniline hydroxylase, respectively. The cytochrome was called P-450 because of its maximal light absorption at 450 nm in a carbon monoxide atmosphere, but we have learned that there are at least two cytochromes, one that handles mainly aliphatic compounds and one that handles mainly aromatic compounds, the latter called cytochrome P-448 [I] or P,-450 [31]. Benzpyrene, found in the tar of cigarettes, is bound to P-448 and is also oxidized by this system by benzpyrene hydroxylase. Several drugs also bind to P-450 or P-488, and some have been studied in great detail. Vinyl chloride, the monomer used to make many plastics, is also metabolized in the biotransformation system but probably by P-448 [30].
The P-450 (or P-448) is reduced by an enzyme (P-450-reductase) containing riboflavin [6]. This enzyme transfers electrons from reduced nicotinamide adenine dinucleotide (NADH) that in turn obtained them from glucose through the hexose monophosphate shunt. In the reduced state, P-450 attracts the molecular oxygen, splits it, and the substrate is hydroxylated and then transferred to another site in the same membrane where it is conjugated. The conjugation can occur with glucuronic acid with the help of glucuronyl transferase, but it can also occur with glutathione to form a mercaptide. These are two main conjugating pathways in the endoplasmic reticulum. The final product is excreted as an organic anion either in the urine or in the bile, depending mainly on its molecular weight.
If the process were as simple as outlined, we would not have any difficulty. We could take drugs in the correct amount, and the liver would either activate them properly or get rid of them properly, but unfortunately, in the metabolic processes two main types of intermediates develop : epoxides and free radicals. Epoxides can form by epoxidation of an aromatic double bond (arene oxides) and with unsaturated aliphatic compounds [12, 131. A simple example of the latter occurs with vinyl chloride. Its double bond can be broken and oxygen inserted for epoxide formation [30] . The same occurs in the rings of aromatic compounds like bromobenzene [13] . The best studied example of free radical formation is carbon tetrachloride metabolism [21] . One chlorine can be split off and the remainder becomes free carbon trichloride, a very reactive moiety, with a positive charge on it. The intermediate epoxides or free radicals are so reactive that they can bind with macromolecules, protein, RNA and DNA in the cell instead of completing the normal metabolic path. Binding can alter protein so that it becomes a new protein and can elicit an immune response. If the protein is a structural part of a vital area, its alteration causes cell injury or death if the cell cannot quickly repair the damage. DNA or RNA macromolecules can also carry information. Alteration of informational macromolecules also can lead to injury cIr necrosis because improper information causes abnormal synthesis of protein that in turn may elicit an immune response. If binding occurs to DNA, even cancer may result.
Toxic Injury
With this sketchy background in molecular pharmacology, we can now look at some of the drug and toxic reactions. The first type is toxic injury or poisoning, exemplified by carbon tetrachloride, which was previously used as a vermifuge. The poison is ingested, absorbed into the system, cleared by the liver and metabolized [3, 21] . As a result of the metabolic process active metabolites are formed that quickly destroy liver cells. These metabolic poisons are concentrated more in the centrolobular zone around the central vein, a relatively anoxic area more sensitive to the action of these toxic substances. The size and staining quality of the cells around the necrotic centrolobular area vary from cell to cell as an indication of injury, and the celk contain fat as an indication of altered metabolic pathways. Impaired lipoprotein synthesis probably accounts for fat accumulation. The phenomenon of necrosis occurs in a dose-related fashion in all species, although the sensitivity varies from one animal group to another. If the animals (or person:;) are fasting for a prolonged period before exposure, the microsomal biotransformation system, which turns over rapidly, is depleted and the volatile car-bon tetrachloride is not metabolized but appears as such in expired air. However, if the animal or patient is on a drug like phenobarbital [24] or on an unbalanced diet, particularly protein-calorie imbalance, the microsomal biotransformation system hypertrophies. Therefore, in a poorly fed individual carbon tetrachloride is more toxic than in a normal individual and much more toxic than in a starved individual. We are exposed to many environmental pollutants. These substances stimulate our microsomal biotransformation almost as though we had taken phenobarbital or other drugs. Because microsomal biotransformation has become induced, toxic substances may indeed become even more noxious. Alcohol can also enhance toxicity under some circumstances, and whether enhancement of carbon tetrachloride poisoning by ethanol is the result of induction of the microsomal ethanol oxidizing system, or whether it is simply due to increasing the solubility of the carbon tetrachloride is not clear. Enhancement can occur acutely so that it is unlikely that induction is involved. In the metabolism of CC14, the free radicals formed rapidly destroy the double bonds of the unsaturated fatty acids in the phospholipids of the endoplasmic reticulum membranes. The molecular assembly in the membrane normally held together by the lipids simply falls apart. The cytochrome P-450 content in the liver after a single exposure to CC14 precipitously drops, and, because repair is slow, it remains depressed for at least a week in rats.
Today there is a great deal of interest in vinyl chloride, not a drug but a common chemical in our environment [30] . This has been called the vinyl era, and it has been estimated that there are two to three million workers in the United States working with polymerized vinyl chloride. Polymerization of the gaseous monomer is carried out in several plants throughout the country. Vinyl chloride is made from either natural gas or petroleum via ethane, ethylene and dichlorethylene. At the cracking plant one chlorine is removed from the last to yield vinyl chloride and hydrochloric acid. The plant where vinyl chloride is made is usually fully automated, and in the process of manufacturing no one is exposed to gaseous vinyl chloride. However, the vinyl chloride liquefies in the refrigerator and is transported in a liquefied form or under increased pressure in tank cars to polymerization plants where several other chemicals are added in big autoclaving vats. The workers in the factories where the vinyl chloride is polymerized were exposed to gaseous vinyl chloride at times in the past in concentrations of several hundred parts per million in the atmosphere. The Environmental Protection Agency, the National Institute for Environmental Health and Safety, and the National Institute of Occupational Safety and Health have been all interested in lower-ing the amount permissible in the air in factories. Now, not more than 50 ppm are permitted, and this may be further reduced. Probably the biggest users of vinyl have been automobile manufacturers, for making tires and seat covers. Much is also used to make food packaging or wrapping material. The workers in the polymerization plants formerly had to go into the autoclaves and scrape down the adherent partially polymerized plastic. These people developed two unrelated diseases, both caused by the vinyl chloride. One was acroosteolysis with disappearance of the bones of terminal phalanges of the hands, and the other was angiosarcomas, mainly in the liver.
Workers in factories where vinyl chloride was polymerized were found hy peritoneoscopy to have fibrosis of the capsule of the liver. The patients sometimes had splenomegaly and also portal hypertension. In autopsy specimens or surgical biopsy specimens from vinyl chloride workers, areas of severe portal fibrosis can be found, and the more portal fibrosis the more likely portal hypertension is to be found, although there are patients with portal hypertension who have only the capsular fibrosis. Hepatic sinusoids become dilated, and abnormal cells begin to appear in the lining of the sinusoids. The end stage is disruption of the liver cell plates and formation of clusters of liver cells surrounded by multiple layers of tumorous mesenchymal cells. The development of this tumor is a modern problem. It was first recognized in a synthetic rubber plant in Louisville, Ky., where a surgeon found three cases of angiosarcoma of the liver in a short span of time [5] . The future of this problem is uncertain. Much money will be invested by the federal government, and basic research as well as epidemiologic studies will be carried out in many institutions. Vinyl-chloride-induced angiosarcoma is only one of several problems related to the plastics industry. About 6000 chemicals are used in this industry, for instance, as hardeners or antioxidants. These can migrate through the plastics after they have been polymerized and come to the surface from which they may be volatilized or ingested. Little information is available as to the metabolism or the toxicology of these compounds.
In a fashion similar to that of CCl, or vinyl chloride, some drugs like methotrexate or 2cetaminophen are metabolized, and the metabolites can produce acute toxicity [18, 20] . With methotrexate a fairly small dose given repeatedly seems to be worse than big doses given infrequently. This drug can produce the same central necrosis as occurs with carbon tetrachloride. Clinically, patients with acute methotrexate toxicity behave like they had viral hepatitis. They complain of anorexia, malaise and fatigability with loss of taste for cigarettes. Jaundice may develop, and transaminase activity in serum is very high. In some of the patients, however, this acute stage is not apparent and patients appear late with very extensive portal fibrosis and indeed often cirrhosis with portal hypertension. Methotrexate-induced fibrosis seems to be related in part to dose and in part to the reactivity in the liver. Metabolites of the methotrexate probably are responsible for fibrosis, perhaps by causing a low-grade hepatocellular injury. When methotrexate (or another folic acid antagonist) is given to children for leukemia, some survive long enough now to develop hepatic fibrosis also. Usual tests of liver function fail to indicate early stages of the fibrosing lesion, and periodic liver biopsies should be done on persons given long-term methotrexate therapy.
Adaptation and Liver Injury
Individuals can adapt to environmental changes by forming more enzymes in the liver, which then enlarges. The induced liver contains more protein and more phospholipid, and the enzyme activity remains elevated as long as the inducer is present. If the inducer is a drug, it is metabolized more rapidly and may become less efficacious, or if it requires activation the dose may become too large [4, 7, 20, 331. With escalating doses it is possible to overcome the ability to adapt [I I]. When adaptation breaks down, the induced steady state cannot be maintained, and decompensation occurs. This experiment was done in rats with the pesticide, dieldrin. The enzyme activity of the microsomal biotransformation system decreased even though the membranes remained hypertrophied. Mitochondria1 damage appeared with loss of some of their enzyme activity. The hypertrophic but hypoactive endoplasmic reticulum is a form of liver injury that can be produced by chemical agents like dieldrin, and possibly some drugs. It can also be caused by cholestasis that in turn resulted from an adverse reaction to a drug.
Unpredictable Reactions
Although we are beginning to better understand toxic liver injury, the clinical problems of recognition, prevention, and treatment of the oftenencountered but unpredictable adverse drug reactions affecting the liver remain unanswered [2,14,20] . These reactions fall into two main categories: a viral-hepatitis-like illness and cholestasis. In recent years chronic hepatitis has been recognized as yet another category. Indeed these categories are not sharply delimited, and considerable overlap is noted so that reactions in-duced by a drug may vary from patient to patient. To try to understand the problem, retention of the three categories (acute hepatitis, cholestasis, and chronic hepatitis) appears justified.
A cute Viral-Hepatitis-Like Reaction
The first drug noted to produce such a reaction was cinchophen, and in the last quarter century several drugs have come and gone because of the hepatitis they produced. Several still widely used drugs, such as halothane, isoniazid, and methyldopa that are capable of producing this reaction remain because the benefits from their use outweigh the risks.
Halothane hepatitis possibly also relates to drug metabolism. Halothane was thought to be metabolically inert until it was recognized that chlorine and bromine could be removed from the molecule and the remainder hydroxylated [26] . The remaining trifluoroethanol is converted to trifluoroacetai:e, and intermediates are postulated but have not been isolated. Free radicals must form during intermediate stages as must trifluoroacetaldehyde. These intermediate compounds should be highly reactive and capable of linking with macromolecules in the cell (DNA, RNA and protein) to cause mitochondrial changes and immune reactions typical of, or responsible for halothane hepatitis. The changes in the cell macromolecules can lead to cell death, and the patterns of necrosis are similar to those seen in viral hepatitis [2i']: spotty necrosis scattered throughout the lobule, confluent necrosis often in the form of linear 'bridges' linking portal tracts and central veins, and massive necrosis involving entire adjacent lobules. The more extensive the necrosis, the less likely recovery will occur, and even if the patient survives, much scarring and even cirrhosis result. In experimental animals, hepatic injury can be enhanced by phenobarbital induction of drug metabolism [23] arid inhibited by decreasing metabolism with aminotriazole, which reduces the cytochrome P-450 content [15] .
The incidence of halothane hepatitis is unknown, but it is very low. It is higher after repeated exposures, and the reaction appears earlier under these circumstances, suggesting that hypersensitivity plays a role. The mortality rate in those affected is high, comparable to that of hepatitis B in the same age group. The hepatitis occurring during isoniazid therapy in selected populations of middle aged adults developed in about one patient in 100 exposed, with a 10% mortality rate. Despite the fact that the hepatitis occurring during therapy with a-methyldopa appears as severe clinically, fatalities are few, for unknown reasons [20] . Therapy for this type of adverse reaction remains supportive, and there is no evidence that corticosteroids are useful.
Cholestasis
Another drug-induced adverse reaction involving the liver is cholestasis. Cholestasis also may result from alteration of the microsomal biotransformation system caused by the drug itself or a metabolite of it [lo] . For instance, a metabolite of chlorpromazine may precipitate with bile salts in the pericanalicular zone. Bile salt metabolism may become abnormal because of drug-induced changes in the microsomal biotransformation system, and abnormal bile salts, such as lithocholate, that produce cholestasis may be formed. Some drugs may interfere with bile salt secretion or impair bile salt independent bile formation and thereby reduce bile flow. The bile thrombi in dilated bile canaliculi that are the hallmarks of cholestasis are found in the centrolobular zone along with bile staining of Kupffer cells and bile-stained and vacuolated hepatocytes (feathery degeneration) [27] .
Many drugs can produce cholestasis, but this adverse reaction rarely is life threatening and so the drugs continue to be used [14, 201. Some, such as 17a-alkylated anabolic or contraceptive steroids, produce cholestasis in a dose-related fashion, and hence reactions are predictable but with great individual dose variations. Other drugs like erythromycin estolate or chlorpromazine produce cholestasis unpredictably, regardless of dosage. Impairment of bile flow can be detected before it produces jaundice, but the methods needed for this are not practical for clinical use. Monitoring of standard liver function tests during therapy will not prevent cholestasis because once the cholestasis process is set in motion it probably cannot be stopped. Therefore, warning the patient to stop therapy if pruritus or dark urine develops probably is the best we can offer. Continuation of a drug after cholestasis develops may result in protracted cholestasis, although in some instances cholestasis may promptly disappear despite continued therapy. Most cholestatic reactions occur in the first several weeks of drug administration, but occasionally cholestasis can occur after many months, especially if therapy is started, stopped, and restarted repeatedly. Once bile flow has decreased in the cholestatic reaction no pharmacologic or physiologic maneuver seems to be capable of starting it again except some natural 'healing' process. Therefore, drug-induced cholestasis is most prudently treated with drug withdrawal only. Not only have attempts at pharmacotherapy proved disap-pointing, but adverse effects of the new therapy can only complicate the problem. The pruritus of drug-induced cholestasis is often not responsive to cholestyramine, antihistamines, steroids, or other drugs. When pruritus is severe, suffering patients need a great deal of personal reassurance and support rather than more medications.
Chronic Hepatitis
A new dimension was added to the adverse drug reactions involving the liver when it was appreciated that chronic liver disease could result after long-term therapy. Several drugs have been involved [9] including oxyphenisatin [25] , isoniazid [16] , sulfonamides [32] , a-methyldopa [17, 28] and even aspirin [29] . The chronic hepatitis that can result may be associated with such immunologic abnormalities as smooth muscle or antinuclear antibodies, and cirrhosis has developed with a fatal outcome in some persons. Oxyphenisatin produces cholestasis acutely, isoniazid produces hepatitis, methyldopa can produce both, and aspirin apparently neither. Therefore the chronic lesion that looks like chronic aggressive hepatitis pathologically bears little or no relation to the acute lesion. The incidence and the mechanism of this chronic hepatitis are unknown, although both drug metabolism and immiinologic factors probably play a role. Whether drug withdrawal is an adequate therapeutic maneuver or whether steroid therapy should be added is undecided. Monitoring of therapy with periodic examinations of liver function may have an important role here, in contrast to the chronic lesion induced by methotrexate.
